Subsequently, mean protein levels of chemerin and CMKLR1 in ovarian cancer subgroups were compared with high vs. low expression of the ovarian cancer markers, cancer-related proteins, and components of estrogen signaling pathways that were analyzed in this study. This evidence concerns the gene RARRES2 and ovarian carcinoma.